ORIC PHARMACEUTICALS, INC. Other Comprehensive Income (Loss), Net of Tax
ORIC PHARMACEUTICALS, INC. (ORIC) reported Other Comprehensive Income (Loss), Net of Tax of -$31.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-23.
Discontinued › Income Statement
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2021-03-23
- ORIC PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax for the quarter ending 2020-09-30 was -$29.00K.
- ORIC PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax for fiscal 2020 was -$31.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|
| 2020-12-31 | -$31.00K 10-K · filed 2021-03-23 | |
| 2020-09-30 | -$29.00K 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |